Kelly Malcom

Lead Research Communicator

Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]

Kelly Malcom photo
hands cutting and tweezing at a dna strip blue pink colors background
Health Lab

Discovery of a “hidden gem” enables gene editing with a small but mighty CRISPR-Cas3 system

Enhanced research tool is a potential boon for research in genetic diseases and developmental biology.
lab notes general image of stethoscope drawn in blue ink on lined paper
Health Lab

Size matters in microbiome studies

The size of a microbiome sample from rectal swabs varies from patient to patient and can predict infection risk.
Hfq DNA Cya Balls blue Circles with dark blue back ground
Health Lab

Bacterial genome is regulated by an ancient molecule

The discovery reveals how bacteria silence potentially deadly genes.
News Release

U-M among four Michigan universities to receive $18.5 million in federal funding to expand sequencing for COVID-19 and other infectious diseases

Four Michigan universities will receive $18.5 million in federal funds over the next two years to collect and analyze genomic data to address emerging infectious disease threats and enhance the state’s ability to respond to those threats, announced the Michigan Department of Health and Human Services (MDHHS) today.
white bacteria under microscope
Health Lab

Form, function and a deadly fungus

A newly developed tool is studying the genetics underlying the emerging fungal pathogen, Candida auris.
City street at night with holiday lights
Health Lab

How to safely celebrate the holidays during COVID-19

Celebrating another holiday season during COVID means that safety guidelines continue to be crucial. Four expert-approved tips for reducing the risk of infection and illness.
News Release

Michigan Medicine increased research output during pandemic year

In early 2020, as Michigan Medicine faculty, learners and staff turned their attention to halting the spread of COVID-19 and providing much-needed care for patients, they also ramped up research efforts to include studies dedicated to understanding the novel coronavirus, SARS-CoV2 and the effects of COVID-19.
paper cut out dna helix hands
Health Lab

Breakthrough in using CRISPR-Cas9 to target fat cells

CRISPR technology is helping researchers study fat cells, and the method could revolutionize the process and cost of developing mouse models for lab research.
Omicron Green O-Virus, multicolor "O" in middle of virus particles on purple and grayish background
Health Lab

What to know about the omicron variant

The Omicron variant of Sars-CoV-2, the virus that causes COVID-19, is the latest in a string of variants. What do we know about Omicron? Will vaccines protect against it? A U-M infectious disease expert explains what we know so far.
pink purple cellular microscopic slide
Health Lab

Pathologists find evidence of pre-existing chronic lung disease in people with long COVID

Some symptoms may be caused by damage developed before patients contracted the coronavirus.
colorful rainbow circles marbles lungs
Health Lab

Taking care of your lungs during COVID and beyond

In the wake of the pandemic, a pulmonologist provides advice on protecting your often-overlooked lung health.
News Release

U-M Health launches mobile COVID-19 vaccination and test verification

Instead of carrying around their CDC-issued vaccine card, University of Michigan Health patients now have the option of displaying a digital copy of their COVID-19 vaccination record and recent COVID-19 test results through the MyUofMHealth patient portal and mobile phone app.
hand and fingers with pulse device oxygen on it
Health Lab

Biased tech could determine who gets life saving therapy

Racial bias in pulse oximeter readings has dire consequences for patients with darker skin. Study shows Black patients critically ill with COVID-19 were three times less likely to receive life saving ECMO treatment than their lighter skinned counterparts
man's arm with eye watch over green field
Health Lab

Apple Watch Study provides an unprecedented look at the health status of a diverse patient population

Participants from the University of Michigan Health-led research range in age, race and health conditions.
Health Lab

Experts answer your most pressing COVID-19 questions

What we know about treatments, vaccines, boosters and more.
  • 12
  • 13
  • 14